中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Pathophysiological Mechanisms of Fibromuscular Dysplasia

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Assistance Publique - Hôpitaux de Paris
合作者
Fondation pour la Recherche Médicale

关键词

抽象

Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery, arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order to progress into identifying possible causative mechanisms of the disease, we design a pathophysiology study destined to assess endothelial function in patients with fibromuscular dysplasia and to identify possible plasmatic biomarkers of the disease.

日期

最后验证: 09/30/2016
首次提交: 09/01/2013
提交的预估入学人数: 09/01/2013
首次发布: 09/04/2013
上次提交的更新: 10/16/2016
最近更新发布: 10/17/2016
实际学习开始日期: 10/31/2011
预计主要完成日期: 09/30/2014
预计完成日期: 09/30/2014

状况或疾病

Fibromuscular Dysplasia

干预/治疗

Other: blood samples

Other: vascular echotracking

-

手臂组

干预/治疗
Other: Fibromuscular dysplasia
Fibromuscular dysplasia:blood samples & vascular echotracking
Other: healthy volunteer
healthy volunteer:blood samples & vascular echotracking
Other: hypertensive patients
hypertensive patients:blood samples & vascular echotracking

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria for patients with multifocal fibromuscular dysplasia:

- confirmed multifocal fibromuscular dysplasia

- diagnosed for less than 10 years

- without significant atherosclerotic disease or recent cardiovascular event

- Statins and antiplatelet drugs are forbidden

- hypertensive patients

结果

主要结果指标

1. Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients [Once within 15 days]

次要成果指标

1. Comparison of circulating micro RNAs (miR-143 ; miR-145) between the 3 arms [Once within 15 days]

2. Comparison of matrixmetalloproteases between the 3 arms [Once within 15 days]

3. Comparison of c-reactive protein between the 3 arms [Once within 15 days]

4. Comparison of PLA2 between the 3 arms [Once within 15 days]

5. Comparison of endothelium dependant vasodilation between the 3 arms [Once within 15 days]

6. Comparison of endothelium independent vasodilation between the 3 arms [Once within 15 days]

7. Comparison of pulse wave velocity between the 3 arms [Once within 15 days]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge